VESSEL PUNCTURE SITE PAIN

VESSEL PUNCTURE SITE PAIN was reported 106 times

These drug classes are most commonly taken by patients reporting VESSEL PUNCTURE SITE PAIN:

# Drug Count
0 Integrin Receptor Antagonist [EPC] 16
1 Corticosteroid [EPC] 13
2 Nonsteroidal Anti-inflammatory Drug [EPC] 11
3 Osmotic Laxative [EPC] 10
4 Tumor Necrosis Factor Blocker [EPC] 8
5 Platelet Aggregation Inhibitor [EPC] 6
6 Proton Pump Inhibitor [EPC] 6
7 Provitamin D2 Compound [EPC] 6
8 Vitamin C [EPC] 6
9 Estrogen [EPC] 5
10 Folate Analog Metabolic Inhibitor [EPC] 5
11 Immunoglobulin G [EPC] 5
12 Interleukin-6 Receptor Antagonist [EPC] 5
13 CD20-directed Cytolytic Antibody [EPC] 4
14 Human Immunoglobulin G [EPC] 4
15 Serotonin-3 Receptor Antagonist [EPC] 4
16 Thiazide Diuretic [EPC] 4
17 Amide Local Anesthetic [EPC] 3
18 Antiarrhythmic [EPC] 3
19 Catecholamine [EPC] 3
20 Endothelin Receptor Antagonist [EPC] 3
21 Ester Local Anesthetic [EPC] 3
22 Expectorant [EPC] 3
23 Loop Diuretic [EPC] 3
24 Non-Standardized Chemical Allergen [EPC] 3
25 alpha-Adrenergic Agonist [EPC] 3
26 beta-Adrenergic Agonist [EPC] 3
27 Angiotensin 2 Receptor Blocker [EPC] 2
28 Aromatase Inhibitor [EPC] 2
29 Arteriolar Vasodilator [EPC] 2
30 Benzodiazepine [EPC] 2
31 Calcium Channel Blocker [EPC] 2
32 Calcium [EPC] 2
33 Complement Inhibitor [EPC] 2
34 Dihydropyridine Calcium Channel Blocker [EPC] 2
35 Factor Xa Inhibitor [EPC] 2
36 Fluoroquinolone Antibacterial [EPC] 2
37 Histamine-1 Receptor Antagonist [EPC] 2
38 Histamine-2 Receptor Antagonist [EPC] 2
39 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 2
40 Insulin Analog [EPC] 2
41 Interferon beta [EPC] 2
42 Interleukin-23 Antagonist [EPC] 2
43 Kinase Inhibitor [EPC] 2
44 Prostacycline Vasodilator [EPC] 2
45 Sulfonylurea [EPC] 2
46 Vitamin B12 [EPC] 2
47 Vitamin D [EPC] 2
48 Aminosalicylate [EPC] 1
49 Anti-epileptic Agent [EPC] 1
50 Antidote [EPC] 1
51 Antidote for Acetaminophen Overdose [EPC] 1
52 Antifibrinolytic Agent [EPC] 1
53 Antirheumatic Agent [EPC] 1
54 Atypical Antipsychotic [EPC] 1
55 Autologous Cellular Immunotherapy [EPC] 1
56 BCL-2 Inhibitor [EPC] 1
57 Barbiturate [EPC] 1
58 Blood Viscosity Reducer [EPC] 1
59 CD52-directed Cytolytic Antibody [EPC] 1
60 Central Nervous System Stimulant [EPC] 1
61 Central alpha-2 Adrenergic Agonist [EPC] 1
62 Copper-containing Intrauterine Device [EPC] 1
63 Epidermal Growth Factor Receptor Antagonist [EPC] 1
64 Ergot Derivative [EPC] 1
65 Folate Analog [EPC] 1
66 GLP-1 Receptor Agonist [EPC] 1
67 HER2/neu Receptor Antagonist [EPC] 1
68 Human C1 Esterase Inhibitor [EPC] 1
69 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
70 Interferon alpha [EPC] 1
71 Interleukin-12 Antagonist [EPC] 1
72 Interleukin-17A Antagonist [EPC] 1
73 Interleukin-4 Receptor alpha Antagonist [EPC] 1
74 Leukotriene Receptor Antagonist [EPC] 1
75 Methylxanthine [EPC] 1
76 Mood Stabilizer [EPC] 1
77 Mucolytic [EPC] 1
78 Muscle Relaxant [EPC] 1
79 Nicotinic Acid [EPC] 1
80 Non-Standardized Food Allergenic Extract [EPC] 1
81 Nucleoside Analog Antiviral [EPC] 1
82 Nucleoside Metabolic Inhibitor [EPC] 1
83 Opioid Agonist [EPC] 1
84 PCSK9 Inhibitor [EPC] 1
85 Parathyroid Hormone Analog [EPC] 1
86 Parenteral Iron Replacement [EPC] 1
87 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
88 Peroxisome Proliferator Receptor gamma Agonist [EPC] 1
89 Platinum-based Drug [EPC] 1
90 Progesterone [EPC] 1
91 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
92 Pyruvate Kinase Activator [EPC] 1
93 RANK Ligand Inhibitor [EPC] 1
94 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1
95 Serotonin Reuptake Inhibitor [EPC] 1
96 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1
97 Soluble Guanylate Cyclase Stimulator [EPC] 1
98 Sympathomimetic-like Agent [EPC] 1
99 Tetracycline-class Drug [EPC] 1
100 Thiazolidinedione [EPC] 1
101 Thyroid Hormone Receptor beta Agonist [EPC] 1
102 Topoisomerase Inhibitor [EPC] 1
103 Vitamin A [EPC] 1
104 Xanthine Oxidase Inhibitor [EPC] 1